Search

everythinglearnresearchcommunity

for

Search:↓

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

TEDAR is crucial for skin cell differentiation and barrier formation.

Interest in JAK inhibitors for alopecia areata increased significantly after FDA approval, highlighting the need for patient education.

WYE-130600 may cause skin thickening and irritation.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Epiregulin can help hair grow and may be useful for treating hair loss.

iEdgePathDDA effectively finds new drug-disease links, outperforming other methods.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Injectable platelet-rich fibrin is better than platelet-rich plasma for promoting hair growth.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

3D imaging effectively tracks skin changes in vitiligo treatment.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.